Skip to main content
. 2025 Aug 3;17(15):2560. doi: 10.3390/cancers17152560
TNT Total neoadjuvant therapy;
LARC Locally advanced rectal cancer;
NOM Non-operative management;
TME Total mesorectal excision;
ctDNA Circulating tumor DNA;
MRD Minimally residual disease;
MMR Mismatch repair;
LE Local excision;
pCR Pathologic complete response;
IRB Institutional review board;
cCR Complete clinical response;
nCR Near complete response;
iCR Incomplete response.